147 related articles for article (PubMed ID: 37080605)
1. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
[TBL] [Abstract][Full Text] [Related]
5. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
7. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
8. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
[TBL] [Abstract][Full Text] [Related]
9. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Bolenz C; Gilfrich C; Otto W; Trojan L; Herrmann E; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
J Urol; 2012 Apr; 187(4):1210-4. PubMed ID: 22335861
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
Tilki D; Svatek RS; Karakiewicz PI; Isbarn H; Reich O; Kassouf W; Fradet Y; Novara G; Fritsche HM; Bastian PJ; Izawa JI; Stief CG; Ficarra V; Lerner SP; Schoenberg M; Dinney CP; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
J Urol; 2010 Jan; 183(1):87-93. PubMed ID: 19942232
[TBL] [Abstract][Full Text] [Related]
11. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
12. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
14. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
15. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Otto W; May M; Fritsche HM; Dragun D; Aziz A; Gierth M; Trojan L; Herrmann E; Moritz R; Ellinger J; Tilki D; Buchner A; Höfner T; Brookman-May S; Nuhn P; Gilfrich C; Roigas J; Zacharias M; Denzinger S; Hohenfellner M; Haferkamp A; Müller SC; Kocot A; Riedmiller H; Wieland WF; Stief CG; Bastian PJ; Burger M
Gend Med; 2012 Dec; 9(6):481-9. PubMed ID: 23217567
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
17. Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
Tachibana I; Mahmoud M; Abedali ZA; Flack C; Adra N; Cheng L; Kaimaklitois HZ
Urol Oncol; 2022 May; 40(5):196.e11-196.e16. PubMed ID: 35148949
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
19. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
Kim HS; Kwak C; Kim HH; Ku JH
Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
[TBL] [Abstract][Full Text] [Related]
20. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
